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Abstract
Background: In the late ‘80s the successes of the laparoscopic surgery for gallbladder disease laid the foundations
on the modern use of this surgical technique in a variety of diseases. In the last 20 years, laparoscopic colorectal
surgery had become a popular treatment option for colorectal cancer patients.
Discussion: Many studies emphasized on the benefits stating the significant advantages of the laparoscopic
approach compared with the open surgery of reduced blood loss, early return of intestinal motility, lower overall
morbidity, and shorter duration of hospital stay, leading to a general agreement on laparoscopic surgery as an
alternative to conventional open surgery for colon cancer. The reduced hospital stay may also decrease the cost of
the laparoscopic surgery for colorectal cancer, despite th higher operative spending compared with open surgery.
The average reduction in total direct costs is difficult to define due to the increasing cost over time, making
challenging the comparisons between studies conducted during a time range of more than 10 years. However,
despite the theoretical advantages of laparoscopic surgery, it is still not considered the standard treatment for
colorectal cancer patients due to technical limitations or the characteristics of the patients that may affect short
and long term outcomes.
Conclusions: The laparoscopic approach to colectomy is slowly gaining acceptance for the management of
colorectal pathology. Laparoscopic surgery for colon cancer demonstrates better short-term outcome, oncologic
safety, and equivalent long-term outcome of open surgery. For rectal cancer, laparoscopic technique can be more
complex depending on the tumor location. The advantages of minimally invasive surgery may translate better care
quality for oncological patients and lead to increased cost saving through the introduction of active enhanced
recovery programs which are likely cost-effective from the perspective of the hospital health-care providers.
Background
Despite the decreased incidence rates reported during
last years, cancer remain the leading cause of death
worldwide [1]. It has been reported that only a small part
of cancers is genetically determined, and most of them is
due to a biological response to environmental factors
[2-6]. Interventions focused on primary prevention
mostly regard tobacco smoking, alcohol consumption,
and dietary advices [7,8], but the burden of the disease is
far to be considered negligible. Regarding the therapeutic
approaches, in the late ‘80s the successes of the laparo-
scopic surgery for gallbladder disease laid the foundations
on the modern use of this surgical technique in a variety
of diseases [9-14]. Among the most frequent benign
and malignant disease which require a surgical therapy,
colorectal cancer has reached the best results with a
laparoscopic approach in terms of safety [15], reduced
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postoperative recovery [16], and improved long-term
survival [17,18].
Thus, in the last 20 years, laparoscopic colorectal sur-
gery had become a popular treatment option for colorectal
cancer patients. Several clinical trials emphasized the
aforementioned benefits stating the significant advantages
of reduced blood loss, early return of intestinal motility,
lower overall morbidity, and shorter duration of hospital
stay in the laparoscopic-assisted group, leading to a gen-
eral agreement on laparoscopic surgery as an alternative to
conventional open surgery for colon cancer. However,
despite the theoretical advantages of laparoscopic surgery,
it is still not considered the standard treatment for color-
ectal cancer patients due to technical limitations or char-
acteristics of the patients that may affect short and long
term outcomes [19]. Thus, the aim of this study is to
review the main available evidences between the conven-
tional open approach and laparoscopic resection of color-
ectal cancer treatment.
Operative parameters
Results about mean operating time of the laparoscopic-
assisted procedure versus open surgery vary among stu-
dies, some reporting no significant differences between
the two groups [20,21] and others reporting a longer
time for the laparoscopic-assisted procedure [22].
The prolonged operative time for the laparoscopic pro-
cedure depend on the higher complexity of technical
expertise involved in such technique. Given the technical
difficulty of this treatment, reasons of such results may
be depended by the need for experienced surgeons and a
not well established manuality due to a consistent learn-
ing curve [23,24]. Major difficulties of the laparoscopic
colorectal surgery are due to work in multiple abdominal
quadrants, control of vascular structures, creation of ana-
stomosis, as well as retrieving large specimens in some
patients whereas potential risks regard port-site recur-
rence after curative resection of tumor and incomplete
lymph node dissection [25,26]. More recent studies are
reporting less significant differences according to this
parameter thanks to the stabilization of the learning
curve of the surgeon. Indeed, in most of the reports, the
learning curve of the technique is incorporated during
the study period and the skills were still evolving during
the conduct of the study, thus is not surprising that as
time passed, the surgeon’s experience with the procedure
increased as well, leading to a decrease of the operative
time in the latter phase of the study period.
Blood loss and analgesic requirement depend greatly
on the degree of invasiveness of the surgical approach.
Results of a recent meta-analysis of clinical trials revealed
a significant increased reduction of intraoperative blood
loss, number of blood transfusions, and abdominal bleed-
ing in patients who underwent a laparoscopic colon
resection compared with those operated with an open
approach [27].
Short-term outcomes
Early randomized controlled trials suggested that the
short-term outcomes of laparoscopic colorectal surgeries
were similar or barely better than the traditional open
approach.
With the establishment of the technique as a routine
surgical approach, a study conducted in 48 institutions
(namely including many surgeons) on 872 patients,
reported that a greater experience of the surgeon (20 or
more laparoscopic resections) was associated with longer
operating time, but better outcomes such as lower
intraoperative complications and shorter recovery time
and hospital stay [28].
The significant improvements in postoperative recov-
ery among laparoscopic-treated patients regard mostly
an earlier resumption of normal diet, shorter hospital
stay, and earlier time to ambulation [20].
However, comparison of length of hospital stay after
surgery among studies may be affected by some con-
founding factors. For instance, socioeconomic status may
lead to health care disparities in countries such as the US
where insurance play an important role on health care of
population. Thus, compared with countries in which the
healthcare system provides ensuring equity in the avail-
ability of care by removing financial barriers for all
patients, the hospital stay of colorectal cancer patients
living in US has been reported to be shorter [29]. Taking
into account such possible bias, a country-specific com-
parison of the length of hospital stay of the patients oper-
ated with the laparoscopic and open procedure still
remain significantly different. Indeed, the postoperative
hospital stay for patients who undergo the laparoscopic
procedure has been reported to range between about 5
and 7 days in US [28,30,31] and slightly longer in coun-
tries in which care are free of charge for all patients [20],
compared with 8 to 10 days for those who undergo open
surgery.
The benefits in short-term outcomes with laparoscopic
resection has been also supported by the reports on peri-
operative immunologic response [32,33]. In the early
post-operative period, better reserved cellular immune
responses such as higher levels of total lymphocytes, CD4
T cell, and CD8 T cell in laparoscopic resection com-
pared with open resection was observed [34]. In some
studies exploring the inflammatory response differences
among different surgical techniques, the immunologically
beneficial IFN-g, produced by the principal effectors of
cell-mediated immunity Th1 cells, seemed to have a
more active presence following laparoscopic colectomy,
potentially contributing to an immunologic “advantage”
by counteracting “harmful” cytokines, such as IL-1
Biondi et al. BMC Surgery 2013, 13(Suppl 2):S12
http://www.biomedcentral.com/1471-2482/13/S2/S12
Page 2 of 6
[35,36]. Better preserved inflammatory function after
surgery may reflect a reduction in operative trauma when
the laparoscopic technique is compared with open
procedures.
Long-term outcomes
Body’s immunologic function, especially cellular immu-
nity, play a central role in preventing cancer recurrence
immediately after surgery of oncological patients [37].
Since the laparoscopic approach limits the tissue trauma
and lead to significant less physiologic alterations during
the perioperative period, it has been hypothesized that
this increased preservation of the immunologic function
may be translated in better long-term oncologic out-
comes and may be correlated with higher postoperative
survival rates [38-40]. Although evidence from early
basic science studies seems to be promising, results
from human studies are contrasting.
In terms of overall survival, disease-free survival, local
or distant recurrence, and long-term quality of life for
colon cancer, recent trials results did not show difference
between the two groups, laparoscopic and laparotomy
resection [41].
Others multicentre and randomized trials have
extended patient recruitment including individuals
affected by rectal cancer, considering the same para-
meters [30,42,43].
Taking into consideration the same data, some authors
have performed some meta-analyses reporting generally
equal long term outcomes [34,44,45]. Oncological safety of
patients operated with laparoscopic approach strongly
depends on the experience of the surgeon, that has been
shown to lead to better long-term outcomes, even when
comparing laparoscopic to open surgery [28,30,42]. The
studies pointed out also the risk connected with conver-
sion rates, which are indeed reduced by increasing the
experience of the surgeon. Some reports suggested that
the conversion to open does not affect the general patient
long-term outcomes [46], whereas others have shown an
increase in the morbidity of inpatients and related out-
comes [47-49]. In most cases the conversion depends on
advanced cancer stage or, among the most reported rea-
sons, on technical difficulties, obesity, and intra-operatory
complications, but since the adverse impact of conversion
has been reported to affect the overall survival (and not
the disease-free survival), this finding is not attributable to
a surgeon-related factor [41].
The problem with incision site recurrences is certainly
not a new issue in surgical oncology, but it remains
unclear whether if laparoscopy is significantly affected by
this issue and what are the mechanisms responsible [50].
For this reason, during the operation, manipulation of
the tumor must be avoided; this is possible thanks to the
use of non-traumatic forceps but above all thanks to the
technique used that provides the fixity of the intestine
during the entire surgery, only at the end, its mobiliza-
tion. The most risky moment is the opening of the
abdominal portion for the extraction of the removed
piece, during which also happens the deflating of the
pneumoperitoneum. The rapid deflation of the pneumo-
peritoneum may determine the so called “chimney effect”
consequently with neoplastic parietal dissemination and
the trocar sites. These two events can be avoided using
small steps such as the use of endobag and a gradual
desufflation with a laparoscopic extractor fan. The
volume and extension of the mass are elements that
affect contamination of surgical instruments during sur-
gery and the consequential dissemination of neoplastic
cells because, when the mass grows on the intestinal ser-
osa or has infiltrated the mesentery and the surrounding
structures, contamination becomes inevitable [51-57].
Previous trials reported higher recurrence rates among
laparoscopic operated patients compared with those
operated with the open approach (up to 80% within 12
months), but latest updates from large randomized con-
trol trials do not confirm such rates, reporting compar-
able results between the two techniques (ranging from
0.5% and 1.3%) [31,54,58].
Incisional hernia and adhesions are also a cause of
postoperative morbidity and predictors of long term
adverse outcome. Regarding incisional hernia, it has
been reported that laparoscopic technique may have
some advantages compared with open surgery [59-61],
due to the absence of a large abdominal wound [62,63].
Moreover, some authors have reported lower rates of
formation of adhesions and related complications in the
laparoscopic compared with open group [64-68].
Cost analysis
Despite the laparoscopic approach has proved as useful for
many benign conditions, including diverticulitis, Crohn’s
disease, and rectal prolapse, the cost-effectiveness and
long-term outcomes for malignancy are less well accepted.
Earlier studies comparing costs from colectomy by the
laparoscopic and open approaches reported conflicting
results. Some studies reported costs for laparoscopic
colectomy to be greater than for open surgery [69,70]
mostly due to higher operative spending for laparoscopy,
rising the doubt that the laparoscopic colorectal resection
could be potentially less cost-effective than open surgery.
Indeed, the care of patients undergoing colorectal surgery
is associated with a variety of direct costs related to the
operating equipment and consumables, anesthesia, labora-
tory, radiology, and pharmacy. The laparoscopic approach
has been demonstrated that require greater costs related
to longer operative time and more expensive equipment.
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On the other hand, studies started to focus on many other
aspects of the comparison between the two techniques,
analyzing whether laparoscopic operating room costs were
balanced by postoperative care savings [71]. Indeed, com-
pared with conventional open resections, laparoscopic col-
orectal resections are associated with less invasive incision
sizes, less postoperative ileus and earlier tolerance of diet
which may contribute to less need for analgesic treatment
and earlier recovery of the patient with a reduced hospital
stay. A faster hospital recovery has been demonstrated to
translate significantly lower total costs owing to lower
pharmacy, laboratory, and ward nursing costs. Reduced
analgesia requirements and lower occurrence of complica-
tions may also decrease costs associated with laparoscopic
treatment. However, studies reporting differences between
the two procedures are equivocal.
The most recent reports concluded that laparoscopic
colorectal resections are significantly cheaper than con-
ventional open resections because of the reduced hospi-
tal stay, despite higher operative spending. The average
reduction in total direct costs is difficult to define due
to the increasing cost over time making comparisons
between studies conducted during a time range of more
than 10 years. Moreover, the costs may vary according
to region or country in which the study was performed.
The saving cost estimated per case has been reported to
range from about $50 to $500. However, the analysis of
the source of such costs demonstrates that this reduc-
tion is derived mostly from nursing care, pharmacy, and
laboratory costs which compensate the increased operat-
ing room expenses incurred by laparoscopic surgery. On
the other hand, newly designed “fast-track” care for
colectomy patients may narrow the distinctions between
hospital stay of laparoscopic and open colectomy
because of the perception that length of stay can be dra-
matically reduced with open surgery [72-75].
Conclusions
The laparoscopic approach to colectomy is slowly gaining
acceptance for the management of colorectal pathology.
Laparoscopic surgery for colon cancer demonstrates better
short-term outcome, oncologic safety, and equivalent
long-term outcome of open surgery. For rectal cancer,
laparoscopic technique can be more complex depending
on the tumor location. However, improvements in health
outcomes have been reported also for rectal location of
cancers, with comparable results to open surgery when
the experience of the surgeon is well established. The
advantages of minimally invasive surgery may translate
better care quality for oncological patients and lead to
increased cost saving through the introduction of active
enhanced recovery programs which are likely cost-effective
from the perspective of the hospital health-care providers.
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